Renaissance Technologies’s SOPHiA GENETICS SOPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$654K Buy
113,300
+53,500
+89% +$271K ﹤0.01% 2499
2026
Q1
$296K Sell
59,800
-23,200
-28% -$113K ﹤0.01% 2793
2025
Q4
$388K Buy
83,000
+52,200
+169% +$236K ﹤0.01% 2676
2025
Q3
$147K Buy
30,800
+10,100
+49% +$34.7K ﹤0.01% 3198
2025
Q2
$64.2K Buy
20,700
+600
+3% +$1.79K ﹤0.01% 3361
2025
Q1
$66.7K Sell
20,100
-800
-4% -$2.81K ﹤0.01% 3252
2024
Q4
$64.2K Sell
20,900
-1,000
-5% -$3.4K ﹤0.01% 3351
2024
Q3
$79.9K Sell
21,900
-100
-0.5% -$406 ﹤0.01% 3290
2024
Q2
$101K Sell
22,000
-900
-4% -$4.39K ﹤0.01% 3183
2024
Q1
$113K Buy
22,900
+1,600
+8% +$7.73K ﹤0.01% 3346
2023
Q4
$100K Buy
21,300
+1,400
+7% +$5.24K ﹤0.01% 3299
2023
Q3
$51K Sell
19,900
-1,700
-8% -$5.39K ﹤0.01% 3401
2023
Q2
$97K Sell
21,600
-2,500
-10% -$11.3K ﹤0.01% 3482
2023
Q1
$120K Buy
24,100
+2,600
+12% +$8.42K ﹤0.01% 3431
2022
Q4
$44K Buy
21,500
+2,500
+13% +$5.61K ﹤0.01% 3819
2022
Q3
$50K Buy
19,000
+1,500
+9% +$5.26K ﹤0.01% 3760
2022
Q2
$63K Buy
+17,500
New +$88.8K ﹤0.01% 3958

Other funds holding SOPH

Renaissance Technologies's SOPH Position: Q2 2026 in Review

Renaissance Technologies increased its SOPHiA GENETICS (SOPH) stake by 89% in Q2 2026, buying an estimated $271K and bringing the position to 113,300 shares worth $654K. The position accounts for ﹤0.01% of the portfolio, ranked #2499.

Renaissance Technologies first reported a position in SOPH in Q2 2022 and has held it in 17 quarters since. 72 funds tracked by Wall St. Rank hold SOPH as of Q2 2026.

  • Renaissance Technologies held 113,300 shares of SOPHiA GENETICS worth $654K as of Q2 2026.
  • Renaissance Technologies bought 53,500 SOPHiA GENETICS shares in Q2 2026, an estimated $271K.
  • SOPHiA GENETICS made up ﹤0.01% of Renaissance Technologies's portfolio in Q2 2026, its #2499 holding.
  • Renaissance Technologies first reported a position in SOPHiA GENETICS in Q2 2022 and has held it in 17 quarters since.
  • 72 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.